Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas. It is manufactured by MEDA Pharma and sold in Switzerland under the brand name Glutril.
via PubMed
{{chembox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 444003955 | ImageFile = Glibornuride.svg | ImageClass = skin-invert-image | ImageSize = 250 | IUPACName = N-{[(1R,2R,3S,4S)-2-Hydroxybornan-3-yl]carbamoyl}-4-methylbenzene-1-sulfonamide | SystematicName = N-{[(1S,2S,3R,4R)-3-Hydroxy-4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl]carbamoyl}-4-methylbenzene-1-sulfonamide | OtherNames =
| Section1 =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).